GFS
REGN icon

GYL Financial Synergies’s Regeneron Pharmaceuticals REGN Stock Holding History

GYL Financial Synergies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.73M Sell
2,600
-52
-2% -$57.9K 0.21% 102
2024
Q2 		$2.79M Sell
2,652
-17
-0.6% -$16.5K 0.22% 98
2024
Q1 		$2.57M Sell
2,669
-83
-3% -$78.9K 0.2% 105
2023
Q4 		$2.42M Buy
2,752
+58
+2% +$47.8K 0.2% 104
2023
Q3 		$2.22M Buy
2,694
+18
+0.7% +$14.1K 0.22% 100
2023
Q2 		$1.92M Buy
+2,676
New +$2.06M 0.18% 114

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

GYL Financial Synergies's REGN Position: Q3 2024 in Review

GYL Financial Synergies reduced its Regeneron Pharmaceuticals (REGN) stake by 2% in Q3 2024, selling an estimated $57.9K and leaving 2,600 shares worth $2.73M. The position accounts for 0.21% of the portfolio, ranked #102.

GYL Financial Synergies first reported a position in REGN in Q2 2023 and has held it in 6 quarters since. The position peaked at $2.79M in Q2 2024. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • GYL Financial Synergies held 2,600 shares of Regeneron Pharmaceuticals worth $2.73M as of Q3 2024.
  • GYL Financial Synergies sold 52 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $57.9K.
  • Regeneron Pharmaceuticals made up 0.21% of GYL Financial Synergies's portfolio in Q3 2024, its #102 holding.
  • GYL Financial Synergies first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • GYL Financial Synergies's Regeneron Pharmaceuticals position peaked at $2.79M in Q2 2024.
  • 1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on GYL Financial Synergies's 13F filing for Q3 2024, filed 7 Nov 2024.